| South London and Maudsley and Oxleas NHS Trusts Prescribing Guidelines D Taylor, R Kerwin, C Paton Taylor and Francis, London, 2005 | 2661* | 2005 |
| Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study RL Carhart-Harris, M Bolstridge, J Rucker, CMJ Day, D Erritzoe, M Kaelen, ... The Lancet Psychiatry 3 (7), 619-627, 2016 | 1536 | 2016 |
| Treatment-resistant schizophrenia: treatment response and resistance in psychosis (TRRIP) working group consensus guidelines on diagnosis and terminology OD Howes, R McCutcheon, O Agid, A De Bartolomeis, NJM Van Beveren, ... American Journal of Psychiatry 174 (3), 216-229, 2017 | 941 | 2017 |
| Psilocybin with psychological support for treatment-resistant depression: six-month follow-up RL Carhart-Harris, M Bolstridge, CMJ Day, J Rucker, R Watts, DE Erritzoe, ... Psychopharmacology 235, 399-408, 2018 | 915 | 2018 |
| Evidence-based guidelines for treating bipolar disorder: revised third edition recommendations from the British Association for Psychopharmacology GM Goodwin, PM Haddad, IN Ferrier, JK Aronson, TRH Barnes, ... Journal of Psychopharmacology 30 (6), 495-553, 2016 | 836 | 2016 |
| Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2008 British Association for Psychopharmacology guidelines A Cleare, CM Pariante, AH Young, IM Anderson, D Christmas, PJ Cowen, ... Journal of Psychopharmacology 29 (5), 459-525, 2015 | 694 | 2015 |
| Atypical antipsychotics and weightgain—a systematic review DM Taylor, R McAskill Acta Psychiatrica Scandinavica 101 (6), 416-432, 2000 | 570 | 2000 |
| Adherence to treatment guidelines in clinical practice: study of antipsychotic treatment prior to clozapine initiation OD Howes, F Vergunst, S Gee, P McGuire, S Kapur, D Taylor The British Journal of Psychiatry 201 (6), 481-485, 2012 | 382 | 2012 |
| Efficacy of drug treatments for generalised anxiety disorder: systematic review and meta-analysis D Baldwin, R Woods, R Lawson, D Taylor Bmj 342, 2011 | 354 | 2011 |
| The role of long-acting injectable antipsychotics in schizophrenia: a critical appraisal S Brissos, MR Veguilla, D Taylor, V Balanzá-Martinez Therapeutic advances in psychopharmacology 4 (5), 198-219, 2014 | 320 | 2014 |
| Should psychiatrists be more cautious about the long-term prophylactic use of antipsychotics? RM Murray, D Quattrone, S Natesan, J Van Os, M Nordentoft, O Howes, ... The British Journal of Psychiatry 209 (5), 361-365, 2016 | 289 | 2016 |
| A systematic review of the evidence of clozapine's anti-aggressive effects C Frogley, D Taylor, G Dickens, M Picchioni International Journal of Neuropsychopharmacology 15 (9), 1351-1371, 2012 | 269 | 2012 |
| International trends in clozapine use: a study in 17 countries CJ Bachmann, L Aagaard, M Bernardo, L Brandt, M Cartabia, A Clavenna, ... Acta Psychiatrica Scandinavica 136 (1), 37-51, 2017 | 257 | 2017 |
| Minimising metabolic and cardiovascular risk in schizophrenia: diabetes, obesity and dyslipidaemia AH Barnett, P Mackin, I Chaudhry, A Farooqi, R Gadsby, A Heald, J Hill, ... Journal of Psychopharmacology 21 (4), 357-373, 2007 | 246 | 2007 |
| Tapering of SSRI treatment to mitigate withdrawal symptoms MA Horowitz, D Taylor The Lancet Psychiatry 6 (6), 538-546, 2019 | 244 | 2019 |
| Antipsychotics and QT prolongation DM Taylor Acta Psychiatrica Scandinavica 107 (2), 85-95, 2003 | 241 | 2003 |
| Psychiatrists’ attitude towards and knowledge of clozapine treatment J Nielsen, M Dahm, H Lublin, D Taylor Journal of Psychopharmacology, 2010 | 238 | 2010 |
| Antidepressant efficacy of agomelatine: meta-analysis of published and unpublished studies D Taylor, A Sparshatt, S Varma, O Olofinjana Bmj 348, 2014 | 235 | 2014 |
| British Association for Psychopharmacology consensus guidance on the use of psychotropic medication preconception, in pregnancy and postpartum 2017 RH McAllister-Williams, DS Baldwin, R Cantwell, A Easter, E Gilvarry, ... Journal of Psychopharmacology 31 (5), 519-552, 2017 | 233 | 2017 |
| A systematic review and meta-analysis of Hypericum perforatum in depression: a comprehensive clinical review E Whiskey, U Werneke, D Taylor International clinical psychopharmacology 16 (5), 239-252, 2001 | 212 | 2001 |
Fiona GaughranProfessor, King's College London在 kcl.ac.uk 的电子邮件经过验证
